Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases? — Ariela Benigni (1998) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?
Shared by
Giuseppe Remuzzi
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?
Article
1998
en
Authors
AB
Ariela Benigni
Giuseppe Remuzzi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
Endothelin Antagonists and Renal Protection
Ariela Benigni
,
Norberto Perico
,
Giuseppe Remuzzi
Article
1997
The renoprotective potential of endothelin receptor antagonists
Ariela Benigni
,
Giuseppe Remuzzi
Article
1997
Progression of proteinuric diabetic and nondiabetic renal diseases: a possible role for renal endothelin.
Giuseppe Remuzzi
,
Ariela Benigni
Article
1998
Angiotensin II receptor antagonists and treatment of hypertension and renal disease
Norberto Perico
,
Giuseppe Remuzzi
Article
1995
Endothelin in the progressive renal disease of glomerulopathies.
Ariela Benigni
,
Giuseppe Remuzzi
.webp)
Discussion(0)
No comments yet. Be the first to comment.